Viewing Study NCT06288334


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-28 @ 1:31 AM
Study NCT ID: NCT06288334
Status: RECRUITING
Last Update Posted: 2024-03-01
First Post: 2024-02-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Sponsor: Peking University Third Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module